John Wiley and Sons: Antifungal and Antidepressant Drugs May Help Protect Against COVID-19
April 10, 2021
April 10, 2021
HOBOKEN, New Jersey, April 10 (TNSJou) -- John Wiley and Sons issued the following news release:
New research published in the British Journal of Pharmacology indicates that two currently available medications--an antifungal drug and an antidepressant--can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Investigators found that the antifungal itraconazole and the antidepressant fluoxetine each blocked the production of infectious SARS-CoV-2 virus . . .
New research published in the British Journal of Pharmacology indicates that two currently available medications--an antifungal drug and an antidepressant--can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Investigators found that the antifungal itraconazole and the antidepressant fluoxetine each blocked the production of infectious SARS-CoV-2 virus . . .